Lead Exposure and Prevention Advisory Committee
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting for the Lead Exposure and Prevention Advisory Committee (LEPAC). This is a hybrid meeting which will occur in person and online and is open to the public. Advance registration by September 29, 2023, is needed to receive the information to attend the meeting. The registration link is provided in the addresses section below.
Full Text
<html>
<head>
<title>Federal Register, Volume 88 Issue 171 (Wednesday, September 6, 2023)</title>
</head>
<body><pre>
[Federal Register Volume 88, Number 171 (Wednesday, September 6, 2023)]
[Notices]
[Pages 60946-60947]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2023-19134]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a hybrid meeting which will occur
in person and online and is open to the public. Advance registration by
September 29, 2023, is needed to receive the information to attend the
meeting. The registration link is provided in the addresses section
below.
DATES: The meeting will be held on October 16, 2023, from 9 a.m. to
4:30 p.m., EDT and October 17, 2023, from 9 a.m. to 1 p.m., EDT.
ADDRESSES: Register in advance at <a href="https://forms.office.com/pages/responsepage.aspx?id=eCgFR53Gc0uxesXQDXVJuPeyypfKOR5Gj2Gz6aPXBGpUREZISTBGVjczTFlLRU5NUjY0SFNaQTM0UC4u&web=1&wdLOR=c61C32E80-28BF-40D7-AC2D-E113AEFDAA23">https://forms.office.com/pages/responsepage.aspx?id=eCgFR53Gc0uxesXQDXVJuPeyypfKOR5Gj2Gz6aPXBGpUREZISTBGVjczTFlLRU5NUjY0SFNaQTM0UC4u&web=1&wdLOR=c61C32E80-28BF-40D7-AC2D-E113AEFDAA23</a> to receive information to attend the meeting.
FOR FURTHER INFORMATION CONTACT: Paul Allwood, Ph.D., M.P.H.,
Designated Federal Officer, National Center for Environmental Health,
Centers for Disease Control and Prevention, 4770 Buford Highway,
Atlanta, Georgia 30341, Telephone: 770-488-6774; Email: <a href="/cdn-cgi/l/email-protection#753930253436351611165b121a03"><span class="__cf_email__" data-cfemail="e0aca5b0a1a3a0838483ce878f96">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21,
Registry for Lead Exposure and Prevention Advisory Committee.
Purpose: The LEPAC is charged with providing advice and guidance to
the Secretary, Department of Health and Human Services (HHS), and the
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal
programs and services available to individual communities exposed to
lead; (2) reviewing current research on lead exposure to identify
additional
[[Page 60947]]
research needs; (3) reviewing and identifying best practices, or the
need for best practices regarding lead screening and the prevention of
lead poisoning; (4) identifying effective services, including services
relating to healthcare, education, and nutrition for individuals and
communities affected by lead exposure and lead poisoning, including in
consultation with, as appropriate, the lead exposure registry as
established in section 2203(b) of Public Law 114-322; and (5)
undertaking any other review or activities that the Secretary
determines to be appropriate.
Matters To Be Considered: The agenda will include presentations on
the following topics: aligning HUD inspection protocols for assisted
housing for the last 20 years, the environmental factors impacting lead
reduction, EPA's proposal on lead dust clearance level and hazard
standard, updates on blood lead testing instrument, lead related
funding opportunities for community-based organizations, state policy
actions related to the blood lead reference value, CDC's efforts to
increase blood lead testing in children enrolled in Medicaid, and an
update from the Preventing Lead Exposure in Adults workgroup. Agenda
items are subject to change as priorities dictate.
Public Participation
Oral Public Comment: The public comment period is scheduled on
October 16, 2023, from 1:30 p.m. until 2 p.m., and October 17, 2023,
from 9:15 a.m. until 9:45 a.m. EDT. Individuals wishing to make a
comment during the public comment period, please email your name,
organization, and phone number by October 1, 2023, to <a href="/cdn-cgi/l/email-protection#1a565f4a5b595a797e79347d756c"><span class="__cf_email__" data-cfemail="d29e9782939192b1b6b1fcb5bda4">[email protected]</span></a>.
The Director, Office of Strategic Business Initiatives, Office of
the Chief Operating Officer, Centers for Disease Control and
Prevention, has been delegated the authority to sign Federal Register
notices pertaining to announcements of meetings and other committee
management activities, for both the Centers for Disease Control and
Prevention and the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-19134 Filed 9-5-23; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.